174 related articles for article (PubMed ID: 21719392)
21. Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.
Wagstaff AJ; Bryson HM
Drugs; 1994 Aug; 48(2):199-226. PubMed ID: 7527325
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma.
De Luca A; Antinori A; Cingolani A; Larocca LM; Linzalone A; Ammassari A; Scerrati M; Roselli R; Tamburrini E; Ortona L
Br J Haematol; 1995 Aug; 90(4):844-9. PubMed ID: 7669663
[TBL] [Abstract][Full Text] [Related]
23. Foscarnet salvage therapy efficacy is associated with the presence of thymidine-associated mutations (TAMs) in HIV-infected patients.
Charpentier C; Laureillard D; Sodqi M; Si-Mohamed A; Karmochkine M; Bélec L; Weiss L; Piketty C
J Clin Virol; 2008 Oct; 43(2):212-5. PubMed ID: 18760662
[TBL] [Abstract][Full Text] [Related]
24. Highly active antiretroviral therapy is associated with improved survival among patients with AIDS-related primary central nervous system non-Hodgkin's lymphoma.
Diamond C; Taylor TH; Im T; Miradi M; Wallace M; Anton-Culver H
Curr HIV Res; 2006 Jul; 4(3):375-8. PubMed ID: 16842088
[TBL] [Abstract][Full Text] [Related]
25. [Systemic HIV-non-Hodgkin lymphoma in the era of HAART. Natural history].
Juzbasic S; Spina M; Vaccher E; Tirelli U
Recenti Prog Med; 2001 Nov; 92(11):676-89. PubMed ID: 11765662
[TBL] [Abstract][Full Text] [Related]
26. Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF.
Errante D; Gabarre J; Ridolfo AL; Rossi G; Nosari AM; Gisselbrecht C; Kerneis Y; Mazzetti F; Vaccher E; Talamini R; Carbone A; Tirelli U
Ann Oncol; 1999 Feb; 10(2):189-95. PubMed ID: 10093688
[TBL] [Abstract][Full Text] [Related]
27. Recombinant interleukin-2 (rIL-2) in acquired immune deficiency syndrome (AIDS): preliminary report in patients with lymphoma associated with HIV infection.
Mazza P; Bocchia M; Tumietto F; Costigliola P; Coronado O; Bandini G; Conte R; Ricchi E; Vianelli N; Raise E
Eur J Haematol; 1992 Jul; 49(1):1-6. PubMed ID: 1354168
[TBL] [Abstract][Full Text] [Related]
28. Drug combination treats brain cancer.
AIDS Patient Care STDS; 1999 Dec; 13(12):755. PubMed ID: 10743546
[No Abstract] [Full Text] [Related]
29. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
[TBL] [Abstract][Full Text] [Related]
30. Measurement of viral sequences in cerebrospinal fluid of AIDS patients with cerebral white-matter lesions using polymerase chain reaction.
Monno L; Di Stefano M; Zimatore GB; Andreula CF; Appice A; Perulli LM; Fiore JR; Pastore G; Angarano G
AIDS; 1998 Apr; 12(6):581-90. PubMed ID: 9583597
[TBL] [Abstract][Full Text] [Related]
31. AIDS-related central nervous system lymphomas.
Chamberlain MC; Kormanik PA
J Neurooncol; 1999 Jul; 43(3):269-76. PubMed ID: 10563433
[TBL] [Abstract][Full Text] [Related]
32. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?
de Pádua Covas Lage LA; Araújo Soares V; Meneguin TD; Culler HF; Reichert CO; Jacomassi MD; Reis DGC; Zerbini MCN; de Oliveira Costa R; Rocha V; Pereira J
Radiat Oncol; 2022 Oct; 17(1):171. PubMed ID: 36273167
[TBL] [Abstract][Full Text] [Related]
33. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART).
Wolf T; Brodt HR; Fichtlscherer S; Mantzsch K; Hoelzer D; Helm EB; Mitrou PS; Chow KU
Leuk Lymphoma; 2005 Feb; 46(2):207-15. PubMed ID: 15621803
[TBL] [Abstract][Full Text] [Related]
34. Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.
Spaulding A; Rutherford GW; Siegfried N
Cochrane Database Syst Rev; 2010 Oct; (10):CD008740. PubMed ID: 20927777
[TBL] [Abstract][Full Text] [Related]
35. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
Gabarre J; Marcelin AG; Azar N; Choquet S; Lévy V; Lévy Y; Tubiana R; Charlotte F; Norol F; Calvez V; Spina M; Vernant JP; Autran B; Leblond V
Haematologica; 2004 Sep; 89(9):1100-8. PubMed ID: 15377471
[TBL] [Abstract][Full Text] [Related]
36. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
37. Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet).
Polis MA; deSmet MD; Baird BF; Mellow S; Falloon J; Davey RT; Kovacs JA; Palestine AG; Nussenblatt RB; Masur H
Am J Med; 1993 Feb; 94(2):175-80. PubMed ID: 8381583
[TBL] [Abstract][Full Text] [Related]
38. Safe substitution to zidovudine among HIV-infected patients initiated on stavudine-containing highly active antiretroviral therapy from a resource-limited setting.
Kumarasamy N; Venkatesh KK; Devaleenol B; Saghayam S; Manohar D; Poongulali S; Yepthomi T; Ambrose P; Solomon S; Mayer KH
Int J Infect Dis; 2009 Nov; 13(6):e360-4. PubMed ID: 19328734
[TBL] [Abstract][Full Text] [Related]
39. Magnitude and associated factors of anemia among AZT based HAART experienced adult HIV patients at University of Gondar Comprehensive Specialized Referral Hospital, Northwest, Ethiopia, 2019: a retrospective cohort study.
Getaneh Z; Wale W; Chanie B; Temesgen E; Abebe M; Walie M; Lemma M
BMC Infect Dis; 2021 Sep; 21(1):1016. PubMed ID: 34583644
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir trial).
Joly V; Flandre P; Meiffredy V; Brun-Vezinet F; Gastaut JA; Goujard C; Remy G; Descamps D; Ruffault A; Certain A; Aboulker JP; Yeni P;
Antimicrob Agents Chemother; 2002 Jun; 46(6):1906-13. PubMed ID: 12019107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
